MCID: ORT004
MIFTS: 65

Orthostatic Intolerance malady

Categories: Genetic diseases, Neuronal diseases, Rare diseases, Mental diseases, Cardiovascular diseases

Aliases & Classifications for Orthostatic Intolerance

About this section

Aliases & Descriptions for Orthostatic Intolerance:

Name: Orthostatic Intolerance 51 24 69 26 12
Mitral Valve Prolapse 11 26 49 37 38 13
Neurocirculatory Asthenia 11 24 38 13 67
Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency 53
Cardiovascular Malfunction Arising from Mental Factors 11
Postural Tachycardia Syndrome Due to Net Deficiency 53
Orthostatic Intolerance Due to Net Deficiency 53
Mitral Valve Prolapse, Familial, X-Linked 67
Myxomatous Mitral Valve Prolapse 11
Mitral Valve Prolapse Syndrome 67
 
Systolic Click-Murmur Syndrome 11
Cardiovascular Neurosis 11
Mitral Leaflet Syndrome 11
Osteogenesis Imperfecta 67
Floppy Mitral Valve 11
Krishaber's Disease 11
Da Costa's Syndrome 11
Barlow's Syndrome 11
Oi 69

Characteristics:

Orphanet epidemiological data:

53

HPO:

63
orthostatic intolerance:
Inheritance: autosomal dominant inheritance

Classifications:



Summaries for Orthostatic Intolerance

About this section
MedlinePlus:37 Mitral valve prolapse (mvp) occurs when one of your heart's valves doesn't work properly. the flaps of the valve are "floppy" and don't close tightly. most people who have the condition are born with it. it also tends to run in families. most of the time, mvp doesn't cause any problems. rarely, blood can leak the wrong way through the floppy valve. this can cause palpitations (feelings that your heart is skipping a beat, fluttering, or beating too hard or too fast) shortness of breath cough fatigue, dizziness, or anxiety migraine headaches chest discomfort most people who have mitral valve prolapse (mvp) don't need treatment because they don't have symptoms and complications. if you need treatment for mvp, medicines can help relieve symptoms or prevent complications. very few people will need surgery to repair or replace the mitral valve. mvp puts you at risk for infective endocarditis, a kind of heart infection. to prevent it, doctors used to prescribe antibiotics before dental work or certain surgeries. now, only people at high risk of endocarditis need the antibiotics. nih: national heart, lung, and blood institute

MalaCards based summary: Orthostatic Intolerance, also known as mitral valve prolapse, is related to osteogenesis imperfecta, type iv and mitral valve prolapse, myxomatous 2, and has symptoms including orthostatic tachycardia, chest pain and chest pain. An important gene associated with Orthostatic Intolerance is SLC6A2 (Solute Carrier Family 6 Member 2), and among its related pathways are NO-dependent CFTR activation (normal and CF) and Effects of nitric oxide. The drugs calcitonin and salmon calcitonin have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and lung, and related mouse phenotypes are integument and renal/urinary system.

Disease Ontology:11 A mitral valve disease where one or both of the cusps of the mitral valve bulge or collapse backward in the left atrium during systole.

UniProtKB/Swiss-Prot:69 Orthostatic intolerance: Syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. It is associated with postural tachycardia. Plasma norepinephrine concentration is abnormally high.

Wikipedia:70 Orthostatic intolerance (OI) is the development of symptoms when standing upright which are relieved... more...

Description from OMIM:51 604715

Related Diseases for Orthostatic Intolerance

About this section

Diseases in the Orthostatic Intolerance family:

Chronic Orthostatic Intolerance

Diseases related to Orthostatic Intolerance via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 91)
idRelated DiseaseScoreTop Affiliating Genes
1osteogenesis imperfecta, type iv33.1COL1A1, COL1A2
2mitral valve prolapse, myxomatous 212.6
3mitral valve prolapse, myxomatous 312.4
4familial mitral valve prolapse12.4
5chronic orthostatic intolerance12.3
6mitral valve prolapse 212.3
7mitral valve prolapse, familial, x-linked12.2
8hypogonadism mitral valve prolapse mental retardation12.1
9mitral valve prolapse, familial, autosomal dominant12.1
10hypogonadism-mitral valve prolapse-intellectual disability syndrome12.1
11osteogenesis imperfecta11.8
12osteogenesis imperfecta, type v11.7
13osteogenesis imperfecta, type viii11.6
14osteogenesis imperfecta, type iii11.6
15osteogenesis imperfecta, type xiii11.6
16osteogenesis imperfecta, type xiv11.6
17osteogenesis imperfecta, type xv11.6
18osteogenesis imperfecta, type i11.6
19osteogenesis imperfecta, type vii11.5
20osteogenesis imperfecta, type xi11.5
21osteogenesis imperfecta, type ii11.5
22osteogenesis imperfecta, type x11.5
23osteogenesis imperfecta, type vi11.5
24osteogenesis imperfecta, type xii11.4
25postural orthostatic tachycardia syndrome11.3
26perinatally lethal osteogenesis imperfecta11.3
27microphthalmia, syndromic 211.1
28dentinogenesis imperfecta11.1
29osteogenesis imperfecta, type ix10.9
30infundibulo-neurohypophysitis10.5COL1A1, COL1A2
31corpus luteum cyst10.4EDN1, NOS3, POMC
32leg dermatosis10.4FBN1, POMC
33contractures-webbed neck-micrognathia-hypoplastic nipples syndrome10.4COL1A1, COL1A2
34larynx carcinoma in situ10.4EDN1, NOS2, NOS3
35pex7-related refsum disease10.4COL1A1, COL1A2
36olfactory neural tumor10.4ECE1, EDN1
37elliptocytosis 310.4COL1A1, COL1A2
38syncope10.4
39spinal canal and spinal cord meningioma10.4EDN1, NOS2, NOS3
40intracranial chondrosarcoma10.3ADRB1, ADRB2
41pervasive developmental disorder10.3ADRA2A, POMC, SLC6A2
42deafness, autosomal recessive 9110.3COL1A1, COL1A2
43broad ligament malignant neoplasm10.3ADRB1, AGTR1, EDN1
44podder-tolmie syndrome10.3ADRB1, ADRB2, AGTR1
45hypopigmentation of eyelid10.3ADRB1, ADRB2, AGTR1
46cerebritis10.3
47chronic fatigue syndrome10.2
48transient refractive change10.2EDN1, NOS3
49joint disorders10.2AGTR1, EDN1, NOS3
50alpha-2-plasmin inhibitor deficiency10.2AGTR1, EDN1, NOS3

Comorbidity relations with Orthostatic Intolerance via Phenotypic Disease Network (PDN):


Anxiety DisorderDysthymic Disorder
Coronary Artery DiseaseEsophagitis
Heart DiseaseHypertension, Essential
Intermediate Coronary SyndromeIschemic Heart Disease

Graphical network of the top 20 diseases related to Orthostatic Intolerance:



Diseases related to orthostatic intolerance

Symptoms for Orthostatic Intolerance

About this section


Clinical features from OMIM:

604715

Human phenotypes related to Orthostatic Intolerance:

 63
id Description HPO Frequency HPO Source Accession
1 orthostatic tachycardia63 HP:0012173

UMLS symptoms related to Orthostatic Intolerance:


chest pain, mitral facies, asthenia, back pain, muscle cramp, sciatica

Drugs & Therapeutics for Orthostatic Intolerance

About this section

Drugs for Orthostatic Intolerance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 264)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoprololapproved, investigationalPhase 4, Phase 220137350-58-6, 51384-51-14171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
DL-metoprolol
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
 
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol slow release
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
2
Droxidopaapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 12823651-95-8443940
Synonyms:
DOPS
Droxydopa
 
L-DOPS
L-Dihydroxyphenylserine
L-Threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
3
MidodrineapprovedPhase 4, Phase 3, Phase 2, Phase 144133163-28-7, 42794-76-34195
Synonyms:
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
()-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-Midodrine hydrochloride
(+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
3092-17-9
3092-17-9 (mono-hydrochloride)
42794-76-3
42794-76-3 (Parent)
43218-56-0
97476-58-9
A 4020 Linz
A-4020 Linz
AB00053715
AC1L1HMJ
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Alphamine
Amatine
BPBio1_000157
BRD-A79981887-003-05-7
BSPBio_000141
BSPBio_003150
C07890
C12H18N2O4
C12H18N2O4.HCl
CHEBI:31847
CHEBI:6933
CHEMBL1200461
CID18340
CID4195
CPD000058833
D01307
D08220
DB00211
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DivK1c_000955
EINECS 255-945-3
EINECS 256-148-3
Gutron
HMS1568H03
HMS1922O03
Hipertan
I06-0865
IDI1_000955
KBio1_000955
KBio2_002121
KBio2_004689
KBio2_007257
 
KBio3_002650
KBioGR_000763
KBioSS_002121
LS-174957
LS-8042
LS-8052
M8277_FLUKA
M8277_SIGMA
MIDODRINE HYDROCHLORIDE
MLS001332567
MLS001332568
MLS002154233
Metligene
Midamine
Midodrin
Midodrina
Midodrina [INN-Spanish]
Midodrine (INN)
Midodrine HCL
Midodrine Monohydrochloride
Midodrine [BAN:INN]
Midodrine [INN:BAN]
Midodrine hydrochloride
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN]
Midodrinum
Midodrinum [INN-Latin]
MolPort-003-666-473
MolPort-003-849-221
N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide
NCGC00095311-01
NCGC00178238-01
NCGC00178238-02
NINDS_000955
Prestwick0_000191
Prestwick1_000191
Prestwick2_000191
Prestwick3_000191
Prestwick_625
Pro-Amatine
Pro-Amatine (TN)
ProAmatine
SAM002564219
SBB066174
SMR000058833
SPBio_001390
SPBio_002062
SPECTRUM1503257
ST-1085
Spectrum2_001545
Spectrum3_001585
Spectrum4_000192
Spectrum5_000962
Spectrum_001641
St 1085
St. Peter 224
TL8002369
TS 701
UNII-59JV96YTXV
UNII-6YE7PBM15H
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
midodrine
4
FludrocortisoneapprovedPhase 4, Phase 126127-31-131378
Synonyms:
(11beta)-9-Fluoro-11,17,21-trihydroxypregn-4-ene-3,20-dione
(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
127-31-1
4-08-00-03427 (Beilstein Handbook Reference)
9 .alpha. FF
9 Fluoro 17 Hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9 alpha FF
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 Hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fludrocortisone
9 alpha-Fluoro-17-Hydroxycorticosterone
9 alpha-Fluorocortisol
9 alpha-Fluorohydrocortisone
9-AF
9-AFH
9-Fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-17-Hydroxycortisone
9-Fluorocortisol
9-Fluorohydrocortisone
9-alpha-Fludrocortisone
9-alpha-Fluoro-17-hydroxycorticosterone
9-alpha-Fluorocortisol
9-alpha-Fluorohydrocortisone
9.alpha.-Fluoro-11.beta.,17.alpha.,21-trihydroxy-4-pregnene-3,20-dione
9.alpha.-Fluoro-17-hydroxycorticosterone
9.alpha.-Fluorocortisol
9.alpha.-Fluorohydrocortisone
9alpha-FLUOROCORTISOL
9alpha-Fludrocortisone
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-4-pregnene-3,20-dione
9alpha-Fluoro-17-hydroxycorticosterone
9alpha-Fluoro-hydrocortisone
9alpha-Fluorocortisol
AC1L1LI8
AC1Q5HJH
Alflorone
Astonin
Astonin H
Astonin Merck
Astonin-H
Astonin-H (TN)
BRN 3014278
 
C07004
C21H29FO5
CHEBI:50885
CHEMBL1201388
CID31378
D005438
D07967
DB00687
DB02478
EINECS 204-833-2
F-COL
F-Cortef
FCOL
Florinef
Fludrocortison
Fludrocortisona
Fludrocortisona [INN-Spanish]
Fludrocortisone
Fludrocortisone (INN)
Fludrocortisone [INN:BAN]
Fludrocortisonum
Fludrocortisonum [INN-Latin]
Fludrocortone
Fludrone
Fludronef
Fluodrocortisone
Fluohydrisone
Fluohydrocortisone
Fluorocortisol
Fluorocortisone
HSDB 3332
Hydrocortisone-9alpha-fluoro
LMST02030103
LS-118690
Merck Brand of Fludrocortisone
Merck, Astonin
MolPort-005-943-437
NCGC00181081-01
NSC 11318
NSC11318
Pregn-4-ene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy- (8CI)
Prestwick_648
StC 1400
U 5963
UNII-U0476M545B
WLN: L E5 B666 OV MUTJ A1 BF CQ E1 FV1Q FQ
ZINC04097304
ZK5
fludrocortisone
5
Propranololapproved, investigationalPhase 4, Phase 2, Phase 1, Early Phase 1216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
6
BisoprololapprovedPhase 46266722-44-92405
Synonyms:
(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol
66722-44-9
AB00514681
AC-18540
AC1L1DLQ
AKOS005110983
ARONIS24082
BISOPROLOL
BPBio1_000373
BSPBio_000339
Bisocor
Bisoprolol
Bisoprolol (USAN/INN)
Bisoprolol Fumarate
Bisoprolol Hemifumarate
Bisoprolol [USAN:BAN:INN]
Bisoprolol fumerate
Bisoprolol hemifumarate
Bisoprololum
Bisoprololum [Latin]
C06852
C18H31NO4
CHEBI:3127
CHEMBL645
CID2405
 
CL-297939
Cardicor
Concor
Condyline
Condylox
D02342
DB00612
Detensiel
EMD-33-512
EMD-33512
Emconcor
Emcor
Euradal
I01-7040
Isoten
L000133
LS-122509
MolPort-005-937-320
Monocor
NCGC00024868-02
NCGC00024868-03
NCGC00024868-04
NCGC00024868-05
Prestwick0_000330
Prestwick1_000330
Prestwick2_000330
Prestwick3_000330
SBB065120
SPBio_002260
Soloc
Soprol
UNII-Y41JS2NL6U
Zebeta
7Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15140
8AnticonvulsantsPhase 4, Phase 2, Phase 12620
9BromidesPhase 4, Phase 2, Phase 1606
10Cholinesterase InhibitorsPhase 4, Phase 2, Phase 1570
11Pyridostigmine BromidePhase 4, Phase 2, Phase 125101-26-8
12SympatholyticsPhase 4, Phase 3, Phase 2, Phase 1555
13Cholinergic AgentsPhase 4, Phase 2, Phase 13846
14Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 2350
15Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14095
16Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 1, Early Phase 12969
17Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11535
18Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117734
19Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11154
20Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 122776
21Autonomic AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 19774
22Vasoconstrictor AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 12027
23Adrenergic AgonistsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 12877
24Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13438
25Antiparkinson AgentsPhase 4, Phase 3, Phase 2, Phase 11527
26Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 3, Phase 110355
27Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 11625
28
Methylprednisoloneapproved, vet_approvedPhase 2, Phase 3115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
29
LevodopaapprovedPhase 3, Phase 1, Early Phase 138859-92-76047
Synonyms:
(-)-(3,4-Dihydroxyphenyl)alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(-)-3-(3,4-dihydroxyphenyl)-L-alanine
(-)-Dopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(−)-3-(3,4-dihydroxyphenyl)-L-alanine
(−)-dopa
.Beta.-(3, 4-Dihydroxyphenyl)alanine
.Beta.-(3,4-Dihydroxyphenyl)-L-alanine
1E83F927-C221-46AA-B90A-81B33C5F3868
2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
23734-74-9
25525-15-9
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-DIHYDROXYPHENYLALANINE
3,4-Dihydroxy-L-phenylalanine
3,4-Dihydroxyphenyl-L-alanine
3,4-Dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine (VAN)
3,4-dihydroxy-L-phenylalanine
3,4-dihydroxyphenylalanine
3-(3,4-Dihydroxypheny
3-(3,4-Dihydroxyphenyl)-L-alanine
3-Hydroxy-L-tyrosine
34241-25-3
37830_FLUKA
587-45-1
59-92-7
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AC-11686
AC1L1LOR
AC1Q4U7F
BIDD:GT0158
BPBio1_000059
BSPBio_000053
BSPBio_002354
Bendopa
Bio-0575
Biodopa
Brocadopa
C00355
C9H11NO4
CAS-59-92-7
CCRIS 3766
CHEBI:15765
CHEMBL1009
CID6047
Cerepap
Cidandopa
D 9628
D00059
D0600
D9628
D9628_SIGMA
DAH
DB01235
DOPA
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
DivK1c_000452
Dopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopal-fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
EINECS 200-445-2
EU-0100454
Eldopal
Eldopar
Eldopatec
Eurodopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS501G14
HSDB 3348
Helfo DOPA
 
Helfo-Dopa
Helfo-dopa
IDI1_000452
IV Levodopa
InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14
Insulamina
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
L Dopa
L(-)-Dopa
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alani
L-(3, 4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
L-.Beta.-(3,4-Dihydroxyphenyl)alanine
L-3,4-Dihydroxyphenylalanine
L-3,4-dihydroxyphenylalanine
L-3-(3,4-Dihydroxyphenyl)-Alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-Hydroxytyrosine
L-4-5-Dihydroxyphenylalanine
L-DOPA
L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa
L-Dihydroxyphenylalanine
L-Dopa
L-O-Dihydroxyphenylalanine
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-o-Hydroxytyrosine
LS-255
Laradopa
Larodopa
Ledopa
Levedopa
Levodopa
Levodopa (JP15/USP)
Levodopa (JP15/USP/INN)
Levodopa [USAN:INN:BAN:JAN]
Levodopum
Levodopum [INN-Latin]
Levopa
Lopac-D-9628
Lopac0_000454
MLS000028514
Maipedopa
MolPort-000-856-937
NCGC00015384-01
NCGC00016270-01
NCGC00016270-06
NCGC00093869-04
NINDS_000452
NSC 118381
NSC118381
PDSP1_001541
PDSP2_001525
Parda
Pardopa
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prestwick_185
Prodopa
Ro 4-6316
S1726_Selleck
SDCCGMLS-0066924.P001
SMR000058312
SPBio_000391
SPBio_001974
SPECTRUM2300205
Sobiodopa
Spectrum2_000496
Spectrum4_000539
Spectrum5_001899
Spectrum_000454
Syndopa
UNII-46627O600J
Veldopa
Weldopa
b-(3,4-Dihydroxyphenyl)-L-alanine
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)alanine
bmse000322
component of Sinemet
l)-L-alanine
nchembio.2007.55-comp26
nchembio.89-comp9
ne
β-(3,4-dihydroxyphenyl)alanine
30
MethyldopaapprovedPhase 3, Phase 114555-30-638853
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate
(-)-a-methyldopa
(-)-alpha-methyldopa
(-)-methyldopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid
(S)-(-)-a-methyldopa
(S)-(-)-alpha-Methyldopa
(S)-(-)-alpha-methyldopa
133161-54-3
1339-75-9
2-Methyl-3-(3,4-dihydroxyphenyl)alanine
3,4-Dihydroxy-2-methylphenylalanine (ACD/Name 4.0)
3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE
3-Hydroxy-.alpha.-methyl-L-tyrosine
3-Hydroxy-alpha-methyl-L-tyrosine
4290-08-8
555-30-6
779-08-8
AC-11671
AC1L20K1
AC1Q29EL
AC1Q29EM
AMD
Aldoclor-150
Aldoclor-250
Aldomet
Aldomet (TN)
Aldometil
Aldomin
Aldoril 15
Aldoril 25
Aldoril D30
Aldoril D50
Aldoril, Dopamet, Dopegyt, Methyldopa
Alpha medopa
Alphamethyldopa
Anhydrous methyldopa
Apo Methyldopa Tab 125mg
Apo Methyldopa Tab 250mg
Apo Methyldopa Tab 500mg
Apo-Methyldopa
Apo-methyldopa
BIDD:GT0620
BPBio1_000365
BSPBio_000331
BSPBio_002021
Bayer 1440 L
Baypresol
Becanta
C07194
CCRIS 4671
CHEBI:61058
CHEMBL459
CID38853
D08205
DB00968
DivK1c_000142
Dopamet
Dopamethyperpax
Dopatec
Dopegit
Dopegyt
Dopergit
EINECS 209-089-2
EU-0100853
Grospisk
HMS1569A13
HMS1920N09
HMS2090B11
HMS2091F04
HMS500H04
HSDB 218
Hyperpax
Hypolag
IDI1_000142
KBio1_000142
KBio2_001417
KBio2_003985
KBio2_006553
KBio3_001521
KBioGR_000547
KBioSS_001417
L(-)-a-Methylalanine
L(-)-alpha-Methylalanine
L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methyl-Alanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine
L-(-)-a-Methyl-a-methyl-Aldomin
L-(-)-alpha-Methyl-alpha-methyl-Aldomin
L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine
L-(a-MD)
L-(alpha-Md)
L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid
L-Methyl Dopa
L-Methyl dopa
 
L-Methyldopa
L-a-Methyl-(3, 4-dihydroxyphenyl)alanine
L-a-Methyldopa
L-alpha-Methyl DOPA
L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine
L-alpha-Methyl-3,4-dihydroxyphenylalanine
L-alpha-Methyldopa
LS-216
LT00847269
Lopac0_000853
METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE)
MK 351
MK-351
MLS000028644
Medomet
Medopa
Medopal
Medopren
Methoplain
Methyl dopa
Methyl-L-dopa
Methyldopa
Methyldopa (INN)
Methyldopa (L,-)
Methyldopa (anhydrous)
Methyldopa 125 Tab 125mg
Methyldopa 250 Tab
Methyldopa 500 Tab 500mg
Methyldopa anhydrous
Methyldopate
Methyldopate HCL
Methyldopum
Methyldopum [INN-Latin]
Metildopa
Metildopa [INN-Spanish]
Mk. b51
MolPort-001-792-485
NCGC00024667-01
NCGC00024667-02
NCGC00024667-03
NCGC00024667-05
NCGC00024667-06
NCGC00024667-08
NCI-C55721
NINDS_000142
NSC 169916
NSC169916
Novo-Medopa Tab 125mg
Novo-Medopa Tab 250mg
Novo-Medopa Tab 500mg
Novomedopa
Nr.C 2294
Nu-Medopa
Nu-Medopa Tab 125mg
Nu-Medopa Tab 250mg
Nu-Medopa Tab 500mg
Nu-medopa
Presinol
Presolisin
Prestwick0_000326
Prestwick1_000326
Prestwick2_000326
Prestwick3_000326
Prestwick_732
S1642_Selleck
SMR000059170
SPBio_001056
SPBio_002252
SPECTRUM1500403
Sedometil
Sembrina
Spectrum2_001068
Spectrum3_000501
Spectrum4_000054
Spectrum5_001295
Spectrum_000937
Tocris-0584
UNII-56LH93261Y
a-Methyl dopa
a-Methyl-L-3,4-dihydroxyphenylalanine
a-Methyl-L-dopa
a-Methyldopa (van)
alpha Medopa
alpha-Methyl dopa
alpha-Methyl-L-3,4-dihydroxyphenylalanine
alpha-Methyl-L-dopa
alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine
alpha-Methyldihydroxyphenylalanine
alpha-Methyldopa
alpha-Methyldopa (VAN)
alpha-Methyldopa (van)
alpha-methyl-L-dopa
l-3-(3,4-Dihydroxyphenyl)-2-methylalanine
l-alpha-Methyldopa
levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine
α-Methyl dopa
α-methyl-L-dopa
31
Mannitolapproved, investigationalPhase 326869-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
32
LosartanapprovedPhase 3, Early Phase 1282114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
33
Prednisoloneapproved, vet_approvedPhase 2, Phase 3115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
34
CarbidopaapprovedPhase 2, Phase 3, Phase 117728860-95-934359, 38101
Synonyms:
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1)
(S)-(-)-carbidopa
(S)-(-)-carbidopa hydrate
(S)-(−)-carbidopa
(S)-alpha--Hydrazino-3,4-dihydroxy-alpha--methyl-benzenepropanoic acid monohydrate
(S)-carbidopa
(S)-carbidopa hydrate
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate
(αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
27925-91-3
28860-95-9
31823-41-3
38821-49-7
AC-1676
AC1L1RFR
AC1L1Z32
AC1Q5QGW
Atamet
BB_SC-5095
Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)
C-126
C-DOPA
C126_SIGMA
C1335_SIGMA
CCRIS 5093
CHEBI:3395
CHEBI:39585
CHEMBL1200748
CHEMBL1201236
CID34359
CID38101
CPD-11550
Carbidopa (anhydrous)
Carbidopa Anhydrous
Carbidopa Monohydrate
Carbidopa [USAN:INN:BAN]
Carbidopa anhydrous
Carbidopa hydrate
Carbidopa, (S)-Isomer
Carbidopa, Entacapone, & Levodopa
Carbidopa-1-wasser
 
Carbidopum
Carbidopum [INN-Latin]
DB00190
EINECS 249-271-9
EU-0100382
HMS2089B12
Hadrazino-alpha-methyldopa
Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate
KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate
L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid
L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid
L-alpha-Methyldopahydrazine
L-α-methyldopahydrazine
LS-77199
Lodosin
Lodosyn
Lodosyn, Carbidopa
Lopac0_000382
MK 486
MK-485
MK-486
MLS000069628
MLS002207014
Methyldopahydrazine
MolPort-003-940-629
MolPort-005-934-181
N-Aminomethyldopa
NCGC00024596-01
NCGC00024596-03
NCGC00024596-05
NCGC00024596-06
S(-)-CARBIDOPA
S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
S-(-)-Carbidopa
S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid
S1891_Selleck
SMP1_000057
SMR000058235
ST055523
Stalevo
Tocris-0455
UNII-KR87B45RGH
UNII-MNX7R8C5VO
alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid
alpha-Methyldopahydrazine
carbidopa
carbidopum monohydricum
35
DopamineapprovedPhase 3, Phase 2, Phase 1375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
36
Metoclopramideapproved, investigationalPhase 3, Phase 1116364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
 
KBio2_004686
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
37
NifedipineapprovedPhase 311221829-25-44485
Synonyms:
101539-70-2
101554-38-5
21829-25-4
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
5-22-04-00268 (Beilstein Handbook Reference)
60299-11-8 (mono-hydrochloride)
AC-11618
AC1L1I9V
AC1Q4254
AKOS002942507
ARONIS24171
AWD Pharma Brand of Nifedipine
Adalat
Adalat (TN)
Adalat 10
Adalat 20
Adalat 5
Adalat CC
Adalat CR
Adalat Crono
Adalat FT
Adalat Ft
Adalat GITS
Adalat GITS 30
Adalat Gits
Adalat Gits 30
Adalat LA
Adalat LP
Adalat Oros
Adalat PA
Adalat Retard
Adalat XL
Adalate
Adalate LP
Adapine
Adapress
Adcock Ingram Brand of Nifedipine
Adipine XL
Afeditab
Afeditab CR
Afeditab CR (TN)
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
Aprical long
BAY 1040
BAY A 1040
BAY-a 1040
BAYa1040
BCBcMAP01_000046
BIDD:GT0442
BIDD:PXR0034
BIM-0050796.0001
BPBio1_000271
BRN 0497773
BSPBio_000245
BSPBio_001391
BSPBio_002071
Bay-1040
Bay-a-1040
Bay1040
Bayer Brand of Nifedipine
Bio-0733
Bio1_000112
Bio1_000601
Bio1_001090
Bio2_000111
Bio2_000591
Bonacid
C07266
C17H18N2O6
CAS-21829-25-4
CBiol_001826
CCRIS 6074
CHEBI:7565
CHEMBL193
CID4485
CPD000058291
Calcibloc
Calcigard
Calcilat
Camont
Cardifen
Cardilat
Cardionorm
Chronadalate
Chronadalate LP
Chronadalate Lp
Citilat
Coracten
Coracten XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
Corotrend
Corynphar
D00437
D009543
DB01115
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
DivK1c_000313
Duranifin
EINECS 244-598-3
EU-0100819
Ecodipi
Ecodipin
Ecodipin E
Emaberin
Fedcor
Fedcor Retard
Fenamon
Fenamon SR
Fenamon Sr
Fenigidin
Fenihidin
Fenihidine
Fortipine LA
Glopir
HMS1361F13
HMS1568M07
HMS1791F13
HMS1920P19
HMS1989F13
HMS2051O03
HMS2089H11
HMS2091H20
 
HMS500P15
Hadipin
Hexadilat
I06-0051
I06-1286
IDI1_000313
IDI1_033861
Infedipin
Introcar
KB-1712P
KBio1_000313
KBio2_000111
KBio2_001459
KBio2_002400
KBio2_002679
KBio2_004027
KBio2_004968
KBio2_005247
KBio2_006595
KBio2_007536
KBio3_000221
KBio3_000222
KBio3_001571
KBio3_002879
KBioGR_000111
KBioGR_000627
KBioGR_002400
KBioSS_000111
KBioSS_001459
KBioSS_002405
KRKA Brand of Nifedipine
Kordafen
Korinfar
L001054
LS-1012
Lopac-N-7634
Lopac0_000819
MLS000028521
MLS000758222
MLS001148146
MLS001401371
Macorel
Megalat
MolPort-000-787-707
MolPort-006-822-492
Monohydrochloride, Nifedipine
Myogard
N 7634
N0528
N1fedilat
N7634_SIGMA
NCGC00015748-01
NCGC00015748-02
NCGC00015748-03
NCGC00015748-06
NCGC00015748-13
NCGC00024983-01
NCGC00024983-02
NCGC00024983-03
NCGC00024983-04
NCGC00024983-05
NCGC00024983-06
NCGC00024983-07
NCGC00024983-08
NCGC00091707-01
NINDS_000313
Nedipin
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifediac
Nifedical
Nifedical XL
Nifedicor
Nifedin
Nifedine
Nifedipine
Nifedipine (JP15/USP/INN)
Nifedipine Bayer Brand
Nifedipine GTIS
Nifedipine KRKA Brand
Nifedipine Monohydrochloride
Nifedipine Orion Brand
Nifedipine Pfizer Brand
Nifedipine Retard
Nifedipine [USAN:BAN:INN:JAN]
Nifedipine-GTIS
Nifedipino
Nifedipino [INN-Spanish]
Nifedipinum
Nifedipinum [INN-Latin]
Nifedipres
Nifedirex LP
Nifelan
Nifelat
Nifelat Q
Nifelate
Nifensar XL
Nificard
Nifidine
Nifipen
Niphedipine
Oprea1_788617
Orion Brand of Nifedipine
Orix
Oxcord
Pfizer Brand of Nifedipine
Pidilat
Prestwick0_000063
Prestwick1_000063
Prestwick2_000063
Prestwick3_000063
Prestwick_357
Procardia
Procardia (TN)
Procardia XL
S1808_Selleck
SAM001246963
SMR000058291
SPBio_001016
SPBio_002166
SPECTRUM1500431
STK735567
Sepamit
Slofedipine XL
Spectrum2_001058
Spectrum3_000516
Spectrum4_000074
Spectrum5_001278
Spectrum_000979
Tensipine MR
Tibricol
Tocris-1075
UNII-I9ZF7L6G2L
Vascard
ZINC19594578
Zenusin
cMAP_000042
nchembio.95-comp13
nifedipine
38Natriuretic AgentsPhase 3, Phase 1, Phase 21645
39diureticsPhase 3, Phase 1, Phase 21372
40Psychotropic DrugsPhase 3, Phase 1, Phase 26279
41Neurotransmitter Uptake InhibitorsPhase 3, Phase 2, Phase 13464
42Dopamine AntagonistsPhase 3, Phase 11083
43DihydroxyphenylalaninePhase 3, Early Phase 1140
44Atomoxetine HydrochloridePhase 3, Phase 2, Phase 1168
45Adrenergic alpha-2 Receptor AgonistsPhase 3, Phase 1, Phase 2911
46Aromatic Amino Acid Decarboxylase InhibitorsPhase 2, Phase 3, Phase 1148
47Tranquilizing AgentsPhase 3, Phase 14164
48Central Nervous System DepressantsPhase 3, Phase 1, Phase 2, Early Phase 112806
49Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 2, Phase 312767
50Methylprednisolone acetatePhase 2, Phase 31153

Interventional clinical trials:

(show top 50)    (show all 192)
idNameStatusNCT IDPhase
1Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)Unknown statusNCT01621464Phase 4
2Radical Prostatectomy and Perioperative Fluid TherapyCompletedNCT00771966Phase 4
3Propranolol to Treat Fainting Due to Sympathoadrenal ImbalanceCompletedNCT00060866Phase 4
4Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01518946Phase 4
5A Study for Patients With Neurogenic Orthostatic HypotensionCompletedNCT00046475Phase 4
6Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic HypotensionCompletedNCT00555880Phase 4
7Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01515865Phase 4
8Clinical Trial for the Prevention of Vasovagal SyncopeCompletedNCT00118482Phase 4
9Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized StudyRecruitingNCT02308124Phase 4
10Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionRecruitingNCT02586623Phase 4
11Dawn Simulation and Postural HypotensionRecruitingNCT02632318Phase 4
12Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IVRecruitingNCT01456481Phase 4
13Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging SubjectsRecruitingNCT02123056Phase 4
14Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)Active, not recruitingNCT02171988Phase 4
15A Phase IV Study in Subjects With Neurogenic Orthostatic HypotensionTerminatedNCT00046163Phase 4
16Post-Exercise Hypotension in Elderly Hypertensive MenUnknown statusNCT02415582Phase 3
17Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty PatientsCompletedNCT02445898Phase 2, Phase 3
18Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip ArthroplastyCompletedNCT01707953Phase 3
19Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3
20A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3
21Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3
22Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3
23A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3
24Stop Vasodepressor Drugs in Reflex SyncopeCompletedNCT02137278Phase 3
25Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSARecruitingNCT02071459Phase 2, Phase 3
26Peripheral Dopamine in Postural Tachycardia SyndromeActive, not recruitingNCT00685919Phase 2, Phase 3
27Treatment of Orthostatic HypotensionEnrolling by invitationNCT00581477Phase 3
28Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart FailureTerminatedNCT00608140Phase 3
29Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis PatientsTerminatedNCT01612078Phase 3
30A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3
31Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan SyndromeWithdrawnNCT01361087Phase 3
32Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve RepairUnknown statusNCT01811537Phase 1, Phase 2
33Orthostatic Hypotension in Children With Acute Febrile IllnessUnknown statusNCT00452712Phase 2
34Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC IUnknown statusNCT02307526Phase 2
35Cardiovascular Effects of Selective I(f)-Channel BlockadeUnknown statusNCT00865917Phase 2
36Fipamezole in Neurogenic Orthostatic HypotensionUnknown statusNCT00758849Phase 2
37The Effect of Ivabradine on Patients With Postural Tachycardia SyndromeUnknown statusNCT01761825Phase 2
38Feasibility Study of a Percutaneous Mitral Valve Repair System.CompletedNCT00209339Phase 1, Phase 2
39Sex Hormones and Orthostatic ToleranceCompletedNCT01153581Phase 2
40Non-Pharmacologic Therapy for Neurocardiogenic SyncopeCompletedNCT00096902Phase 2
41Propranolol to Treat Fainting in Children With Sympathoadrenal ImbalanceCompletedNCT00093860Phase 2
42Intravenous Norepinephrine for Orthostatic HypotensionCompletedNCT01285908Phase 1, Phase 2
43Phase II Study of Midodrine for Neurogenic Orthostatic HypotensionCompletedNCT00004268Phase 2
44Transcranial Electrical Stimulation for Management of Orthostatic Instability in Acute Cervical Spinal Cord InjuryCompletedNCT01874782Phase 2
45Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)CompletedNCT01971008Phase 2
46A Dose Response Trial Using 5 and 10 Mg of Midodrine HydrochlorideCompletedNCT00426842Phase 2
47Safety and Efficacy of L-NAME and Midodrine to Increase MAPCompletedNCT00835224Phase 2
48Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood DonationsCompletedNCT00302900Phase 2
49Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)RecruitingNCT02558972Phase 2
50TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)RecruitingNCT02705755Phase 2

Search NIH Clinical Center for Orthostatic Intolerance

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: mitral valve prolapse

Genetic Tests for Orthostatic Intolerance

About this section

Genetic tests related to Orthostatic Intolerance:

id Genetic test Affiliating Genes
1 Orthostatic Intolerance26 24 SLC6A2
2 Mitral Valve Prolapse26

Anatomical Context for Orthostatic Intolerance

About this section

MalaCards organs/tissues related to Orthostatic Intolerance:

35
Heart, Brain, Lung, Testes, Spinal cord, Endothelial, Eye

Animal Models for Orthostatic Intolerance or affiliated genes

About this section

MGI Mouse Phenotypes related to Orthostatic Intolerance:

40 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107719.5COL1A1, COL1A2, DBH, ECE1, FBN1, NOS2
2MP:00053678.9ADRA2B, AGTR1, COL1A1, EDN1, FBN1, NOS2
3MP:00053798.8ADRB1, ADRB2, COL1A1, DBH, ECE1, EDN1
4MP:00053698.4ACHE, ADRA2B, ADRB1, ADRB2, COL1A1, COL1A2
5MP:00053758.3ACHE, ADRB1, ADRB2, AGTR1, COL1A1, COL1A2
6MP:00053908.0ADRB1, ADRB2, COL1A1, COL1A2, DBH, ECE1
7MP:00053977.7ACHE, ADRA2B, ADRB2, AGTR1, COL1A1, ECE1
8MP:00053867.4ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB2, AGTR1
9MP:00053787.3ACHE, ADRA2B, ADRB1, ADRB2, AGTR1, COL1A1
10MP:00036317.3ACHE, ADRA2A, ADRA2C, ADRB2, AGTR1, COL1A1
11MP:00107687.1ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB1, AGTR1
12MP:00053857.0ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, AGTR1
13MP:00053765.2ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2

Publications for Orthostatic Intolerance

About this section

Articles related to Orthostatic Intolerance:

(show top 50)    (show all 272)
idTitleAuthorsYear
1
Detailed Relationship Between the Pattern of Blood Pressure Change During the Valsalva Maneuver and the Degree of Orthostatic Hypotension During the Head-Up Tilt Test in Patients With Orthostatic Intolerance: A Retrospective Case-Control Study. (27175668)
2016
2
Orthostatic hypertension: An underestimated cause of orthostatic intolerance. (26806722)
2016
3
Orthostatic Intolerance After ISS and Space Shuttle Missions. (26630196)
2015
4
Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. (25882168)
2015
5
Slower lower limb blood pooling in young women with orthostatic intolerance. (25557726)
2015
6
Neuropeptides and peptide hormones in syncope and orthostatic intolerance. (25299506)
2014
7
Common syndromes of orthostatic intolerance. (23569093)
2013
8
Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. (23616159)
2013
9
Orthostatic intolerance and chronic fatigue syndrome--possible related conditions. (24340521)
2013
10
Postural tachycardia and orthostatic intolerance: chicken, egg or unrelated? (24190228)
2013
11
Orthostatic intolerance: postural orthostatic tachycardia syndrome with overlapping vasovagal syncope. (22920009)
2012
12
Orthostatic intolerance in multifocal acquired demyelinating sensory and motor neuropathy. (22922580)
2012
13
Temporal artery flow response during the last minute of a head up tilt test, in relation with orthostatic intolerance after a 60 day head-down bedrest. (22073117)
2011
14
Orthostatic intolerance and coronary reserve: a matter of a certain gravity. (21136305)
2011
15
Gradient compression garments as a countermeasure to post-spaceflight orthostatic intolerance. (20824997)
2010
16
Cardio-postural deconditioning: A model for post-flight orthostatic intolerance. (19379846)
2009
17
Physiologic neurocirculatory patterns in the head-up tilt test in children with orthostatic intolerance. (18353058)
2008
18
Effect of thigh cuffs on haemodynamic changes of the middle cerebral artery and on orthostatic intolerance induced by 10 days head-down bed rest. (18565193)
2008
19
Treatment of chronic fatigue and orthostatic intolerance with propranolol. (17517256)
2007
20
Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome. (17263876)
2007
21
Approach to the evaluation of small fiber peripheral neuropathy and disorders of orthostatic intolerance. (17701872)
2007
22
Cerebral blood flow during supine rest and the first minute of head-up tilt in patients with orthostatic intolerance. (16087110)
2005
23
Head-down bed rest reduces the breathing rate short-term variability in subjects with orthostatic intolerance. (16235432)
2004
24
Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome. (15379740)
2004
25
Role of individual predisposition in orthostatic intolerance before and after simulated microgravity. (15075309)
2004
26
Exercise training and orthostatic intolerance: a paradox? (12837932)
2003
27
Mutual information detects a decreased interdependence between RR and SAP in orthostatic intolerance after microgravity condition. (15002504)
2002
28
Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. (11804991)
2002
29
Therapeutic strategies for orthostatic intolerance: mechanisms, observations, and making patients feel better. (11904120)
2002
30
Lower-body negative-pressure exercise and bed-rest-mediated orthostatic intolerance. (12218737)
2002
31
Orthostatic intolerance. (12147938)
2002
32
Enhanced flow-dependent vasodilatation after bed rest, a possible mechanism for orthostatic intolerance in humans. (11606010)
2001
33
Doppler measurement of cerebral and lower limb flow during a lower body negative pressure test for predicting orthostatic intolerance. (11758026)
2001
34
Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome. (11007589)
2000
35
Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. (11198485)
2000
36
Cardiovascular peripheral effector mechanism in postflight orthostatic intolerance: a simulation study. (12697528)
2000
37
The epidemic of orthostatic tachycardia and orthostatic intolerance. (10037110)
1999
38
Assessment of capillary fluid shifts during orthostatic stress in normal subjects and subjects with orthostatic intolerance. (10225610)
1999
39
Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. (10518084)
1999
40
Idiopathic orthostatic intolerance and postural tachycardia syndromes. (10037112)
1999
41
Ethanol ingestion prolongs orthostatic intolerance in hyperthermic humans. (9641404)
1998
42
Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? (9815863)
1998
43
Post-spaceflight orthostatic intolerance: possible relationship to microgravity-induced plasticity in the vestibular system. (9795146)
1998
44
The physiological conundrum of hyperadrenergic orthostatic intolerance. (9170549)
1997
45
Orthostatic intolerance after spaceflight. (8828642)
1996
46
Mechanisms of post-flight orthostatic intolerance. (11538739)
1994
47
Autogenic-feedback training: a potential treatment for orthostatic intolerance in aerospace crews. (8083391)
1994
48
Computer simulation analysis of the effects of countermeasures for reentry orthostatic intolerance. (1589489)
1992
49
Drug effects on orthostatic intolerance induced by bedrest. (1761730)
1991
50
Blood pressure and plasma renin activity as predictors of orthostatic intolerance. (3907614)
1985

Variations for Orthostatic Intolerance

About this section

UniProtKB/Swiss-Prot genetic disease variations for Orthostatic Intolerance:

69
id Symbol AA change Variation ID SNP ID
1SLC6A2p.Ala457ProVAR_010022rs121918126

Clinvar genetic disease variations for Orthostatic Intolerance:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SLC6A2NM_001172504.1(SLC6A2): c.1369G> C (p.Ala457Pro)SNVPathogenicrs121918126GRCh37Chr 16, 55731917: 55731917
2COL1A1NM_000088.3(COL1A1): c.994G> A (p.Gly332Arg)SNVPathogenicrs72645357GRCh37Chr 17, 48273524: 48273524
3COL1A1NM_000088.3(COL1A1): c.787G> A (p.Gly263Arg)SNVPathogenicrs72645323GRCh37Chr 17, 48274388: 48274388
4COL1A1NM_000088.3(COL1A1): c.1200+1G> ASNVPathogenicrs72648320GRCh37Chr 17, 48272794: 48272794
5COL1A1NM_000088.3(COL1A1): c.2161C> T (p.Gln721Ter)SNVLikely pathogenic, Pathogenicrs193922145GRCh37Chr 17, 48268818: 48268818
6COL1A1NM_000088.3(COL1A1): c.3076C> T (p.Arg1026Ter)SNVPathogenicrs72653173GRCh37Chr 17, 48266126: 48266126
7COL1A2NM_000089.3(COL1A2): c.838G> A (p.Gly280Ser)SNVPathogenicrs72656387GRCh37Chr 7, 94038679: 94038679

Expression for genes affiliated with Orthostatic Intolerance

About this section
Search GEO for disease gene expression data for Orthostatic Intolerance.

Pathways for genes affiliated with Orthostatic Intolerance

About this section

Pathways related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathwaysScoreTop Affiliating Genes
19.8NOS2, NOS3
29.8NOS2, NOS3
39.8COL1A1, COL1A2, NOS2
4
Show member pathways
9.7ACHE, DBH, SLC6A2
59.6ECE1, NOS3, POMC
69.6ADRA2A, ADRB1, ADRB2
79.6EDN1, NOS2, NOS3
89.5ADRB1, ADRB2, AGTR1
9
Show member pathways
9.5ADRA2A, ADRA2B, ADRA2C
109.4ADRB1, ECE1, EDN1, NOS3
11
Show member pathways
9.0AGTR1, COL1A1, COL1A2, EDN1, NOS3
129.0AGTR1, COL1A1, COL1A2, EDN1, NOS3
13
Show member pathways
9.0ADRA2A, ADRA2B, ADRB1, ADRB2, EDN1
14
Show member pathways
9.0ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
158.9ADRB1, ADRB2, AGTR1, NOS2, NOS3
16
Show member pathways
8.8ADRA2A, ADRA2B, ADRA2C, NOS2, NOS3
178.6ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DBH
18
Show member pathways
8.2ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, AGTR1
19
Show member pathways
8.0ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, AGTR1

GO Terms for genes affiliated with Orthostatic Intolerance

About this section

Cellular components related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Weibel-Palade bodyGO:003309310.7ECE1, EDN1
2collagen type I trimerGO:000558410.7COL1A1, COL1A2
3secretory granule lumenGO:003477410.4DBH, POMC
4extracellular spaceGO:00056158.7ACHE, COL1A1, COL1A2, DBH, EDN1, FBN1
5integral component of plasma membraneGO:00058878.3ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, AGTR1

Biological processes related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 40)
idNameGO IDScoreTop Affiliating Genes
1vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressureGO:000202510.7ADRB1, ADRB2
2heat generationGO:003164910.7ADRB1, ADRB2
3skin morphogenesisGO:004358910.6COL1A1, COL1A2
4protein heterotrimerizationGO:007020810.6COL1A1, COL1A2
5negative regulation of multicellular organism growthGO:004001510.6ADRB1, ADRB2
6diet induced thermogenesisGO:000202410.5ADRB1, ADRB2
7peptide hormone processingGO:001648610.5ECE1, POMC
8negative regulation of uterine smooth muscle contractionGO:007047310.5ADRA2A, ADRA2C
9response to dexamethasoneGO:007154810.5ADRB2, EDN1
10positive regulation of guanylate cyclase activityGO:003128410.5NOS2, NOS3
11regulation of vasodilationGO:004231210.4AGTR1, ECE1
12cellular response to transforming growth factor beta stimulusGO:007156010.3COL1A1, EDN1, FBN1
13regulation of systemic arterial blood pressure by endothelinGO:000310010.3ECE1, EDN1, NOS3
14negative regulation of calcium ion transportGO:005192610.3ADRA2A, NOS3
15fear responseGO:004259610.2ADRB1, DBH
16response to muscle stretchGO:003599410.2ECE1, EDN1
17arginine catabolic processGO:000652710.2NOS2, NOS3
18epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathwayGO:003562510.2ADRA2A, ADRA2B, ADRA2C
19regulation of sensory perception of painGO:005193010.2ADRA2C, ADRB2, EDN1
20activation of MAPK activity by adrenergic receptor signaling pathwayGO:007188310.2ADRA2A, ADRA2B, ADRA2C
21nitric oxide biosynthetic processGO:000680910.1NOS2, NOS3
22activation of protein kinase B activityGO:003214810.1ADRA2A, ADRA2B, ADRA2C
23negative regulation of cAMP biosynthetic processGO:003081810.0ADRA2A, EDN1
24regulation of insulin secretionGO:005079610.0ADRA2A, ADRA2C, NOS2
25negative regulation of norepinephrine secretionGO:001070010.0ADRA2A, ADRA2B, ADRA2C
26negative regulation of epinephrine secretionGO:003281110.0ADRA2A, ADRA2B, ADRA2C
27glucose homeostasisGO:004259310.0ADRA2A, DBH, POMC
28skeletal system developmentGO:00015019.9COL1A1, COL1A2, EDN1, FBN1
29Rho protein signal transductionGO:00072669.9ADRA2A, AGTR1, COL1A2
30positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayGO:00514829.8AGTR1, EDN1
31positive regulation of potassium ion transportGO:00432689.7ADRA2A, ADRB2
32regulation of blood pressureGO:00082179.7COL1A2, EDN1, NOS3, POMC
33positive regulation of vasodilationGO:00459099.6ADRA2A, ADRB2, NOS2, NOS3
34female pregnancyGO:00075659.6ADRA2A, ADRA2B, ADRA2C, ADRB2
35extracellular matrix organizationGO:00301989.5ADAMTSL4, COL1A1, COL1A2, FBN1
36regulation of vasoconstrictionGO:00192299.4ADRA2A, ADRA2B, AGTR1, ECE1, EDN1
37platelet activationGO:00301689.4ADRA2A, ADRA2B, ADRA2C, COL1A1, COL1A2
38cell-cell signalingGO:00072679.2ADRA2B, ADRA2C, ADRB1, ADRB2, EDN1, POMC
39response to hypoxiaGO:00016669.1ECE1, EDN1, NOS2, PDLIM1
40adenylate cyclase-activating adrenergic receptor signaling pathwayGO:00718808.7ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2

Molecular functions related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1alpha-2A adrenergic receptor bindingGO:003169410.8ADRA2C, ADRB1
2platelet-derived growth factor bindingGO:004840710.7COL1A1, COL1A2
3nitric-oxide synthase activityGO:000451710.6NOS2, NOS3
4arginine bindingGO:003461810.6NOS2, NOS3
5tetrahydrobiopterin bindingGO:003461710.6NOS2, NOS3
6extracellular matrix structural constituentGO:000520110.5COL1A1, COL1A2, FBN1
7hormone activityGO:000517910.4EDN1, FBN1, POMC
8norepinephrine bindingGO:005138010.4ADRA2A, ADRB1, ADRB2
9FMN bindingGO:001018110.4NOS2, NOS3
10alpha2-adrenergic receptor activityGO:000493810.3ADRA2A, ADRA2B, ADRA2C
11epinephrine bindingGO:00513799.8ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
12protein homodimerization activityGO:00428038.5ACHE, ADRA2A, ADRA2C, ADRB2, ECE1, NOS2
13protein bindingGO:00055155.1ACHE, ADAMTSL4, ADRA2A, ADRA2B, ADRA2C, ADRB1

Sources for Orthostatic Intolerance

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet